The chemical synthesis sector is fundamental to the advancement of pharmaceuticals, providing the intricate building blocks necessary for creating life-saving medicines. High-purity intermediates are the bedrock of this endeavor, ensuring the efficacy, safety, and consistency of the final drug product. Among these vital components, 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline (CAS: 1021426-42-5) stands out for its crucial role in the development of advanced therapeutic agents.

This particular aniline derivative is indispensable in the synthesis pathway of CO-1686, a targeted inhibitor being developed for specific types of non-small cell lung cancer. The demand for such specialized intermediates underscores the need for robust chemical synthesis solutions. Pharmaceutical companies and research institutions require suppliers who can consistently deliver materials meeting stringent purity standards, often requiring an assay of 98.0% or higher, and detailed specifications such as its appearance as a brown powder.

For organizations looking to buy 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline, partnering with experienced chemical synthesis providers, particularly those based in China, can offer significant advantages. These manufacturers often possess advanced technological capabilities and economies of scale that enable competitive pricing for critical materials like this CO-1686 intermediate. Identifying a credible 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline manufacturer means looking for a company with a strong reputation for quality control, timely delivery, and comprehensive product documentation.

Procurement specialists often initiate their search by looking for ‘CAS 1021426-42-5 supplier’ to pinpoint potential partners. The ability of a supplier to provide consistent batch quality, adhere to regulatory requirements, and offer technical support is crucial. These synthesis solutions are not just about the product itself, but also about the reliability of the supply chain and the expertise of the manufacturer.

In summary, accessing high-purity chemical intermediates like 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline is a critical factor in the success of pharmaceutical R&D and manufacturing. By carefully selecting synthesis solution providers and focusing on quality and reliability, companies can accelerate their drug development programs and bring innovative treatments to patients more effectively.